-Neal L Benowitz Researcher Activity Profile

Research Author Detailed Information 

Neal L Benowitz Publication Rate By Year

Neal L Benowitz has published 7 paper(s) in 2006, 28 paper(s) in 2007, 6 paper(s) in 2008, for a total of 41 research publications in total.

Neal L Nl Benowitz Author Information

LAST NAME: benowitz

FIRST NAME: Neal L

INITIALS: nl

AFFILIATION:

Papers

Neal L Benowitz's Publication Record

1. Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. Year Published: 2006
Centre for Addiction & Mental Health, and Department of Pharmacology, University of Toronto, Toronto, ON, Canada.
2. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Year Published: 2006
School of Public Health, University of California, Berkeley, California 94720, USA. gblock@berkeley.edu
3. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Year Published: 2006
Division of Biostatistics, Department of Oncology, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
4. Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure. Year Published: 2006
Department of Psychology, Graduate School of Public Health, San Diego, CA, USA. gmatt@sciences.sdsu.edu
5. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Year Published: 2006
Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, and Department of Medicine, University of California, San Francisco, San Francisco 94143-1220, USA. nbenowitz@medsfgh.ucsf.edu
6. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. Year Published: 2006
Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, and Department of Medicine, University of California, San Francisco 94143-1220, USA.
7. Pharmacogenomics: challenges and opportunities. Year Published: 2006
Vanderbilt University, Nashville, Tennessee, USA. dan.roden@vanderbilt.edu
8. Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Year Published: 2007
Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, Department of Medicine, University of California, San Francisco, San Francisco, California 94110, USA. peyton.jacob@ucsf.edu
9. Population pharmacokinetics of nicotine and its metabolites I. Model development. Year Published: 2007
Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, University of California, San Francisco, San Francisco General Hospital Medical Center, San Francisco, CA 94143-1220, USA.
10. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. Year Published: 2007
Department of Biopharmaceutical Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-1220, USA.
11. The pharmacogenetics research network: from SNP discovery to clinical drug response. Year Published: 2007
Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, USA. kathy.giacomini@ucsf.edu
12. Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men. Year Published: 2007
SAIC-Frederick, Inc., support to Tobacco Control Research Branch (TCRB), Behavioral Research Program (BRP), Division of Cancer Control and Population Sciences (DCCPS), National Cancer Institute. Bethesda, MD. mabryp@od.nih.gov
13. The variability of urinary cotinine levels in young children: implications for measuring ETS exposure. Year Published: 2007
Department of Psychology, San Diego State University, San Diego 92182-4611, CA, USA. gmatt@sciences.sdsu.edu
14. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Year Published: 2007
Division of Adolescent Medicine, University of California, San Francisco, San Francisco, CA 94118, USA. mrubin@itsa.ucsf.edu
15. Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults. Year Published: 2007
Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA. dbk2@columbia.edu
16. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Year Published: 2007
Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Hermann Pressler Boulevard, Houston, TX 77030, USA.
17. Genetic and environmental sources of variation in heart rate response to infused nicotine in twins. Year Published: 2007
Center for Health Sciences, SRI International, Menlo Park, CA 94025, USA. gary.swan@sri.com
18. Cigarette smoking and the personalization of irinotecan therapy. Year Published: 2007
19. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine. Year Published: 2007
The Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. stepa011@umn.edu
20. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Year Published: 2007
UMDNJ-Robert Wood Johnson Medical School and UMDNJ-School of Public Health Tobacco Dependence Program, New Brunswick, NJ 08901, USA. jill.williams@umdnj.edu
21. Translational research in medication development for nicotine dependence. Year Published: 2007
Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, Pennsylvania 19104, USA. clerman@mail.med.upenn.edu
22. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Year Published: 2007
Department of Psychology, University of Colorado at Boulder, Boulder, CO 80309, USA. Kent.Hutchison@colorado.edu
23. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Year Published: 2007
Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Hermann Pressler Boulevard, Houston, TX 77030, USA.
24. Vaporization as a smokeless cannabis delivery system: a pilot study. Year Published: 2007
Community Consortium, Positive Health Program, San Francisco General Hospital, San Francisco, California, USA. dabrams@php.ucsf.edu
25. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Year Published: 2007
Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, Box 1220, San Francisco, CA 94143-1220. NBenowitz@MedSFGH.ucsf.edu.
26. Cytisine for smoking cessation: A research agenda. Year Published: 2007
Institute of Social and Preventive Medicine, University of Geneva, CMU, Case Postale, CH-1211 Geneva 4, Switzerland.
27. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Year Published: 2007
Center for Health Sciences, SRI International, Menlo Park, CA, USA. huijun1@yahoo.com
28. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Year Published: 2007
Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, Department of Medicine, University of California, San Francisco, CA 94143-1220, USA. NBenowitz@MedSFGH.ucsf.edu
29. Translational research in medication development for nicotine dependence. Year Published: 2007
Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, Pennsylvania 19104, USA. clerman@mail.med.upenn.edu
30. Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism. Year Published: 2007
1Department of Pharmacology, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
31. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Year Published: 2007
Department of Pharmacology, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
32. The Women's Initiative for Nonsmoking (WINS) XI: Age-Related Differences in Smoking Cessation Responses Among Women With Cardiovascular Disease. Year Published: 2008
From the University of California San Francisco, San Francisco, CA.
33. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Year Published: 2007
Center for Health Sciences, SRI International, Menlo Park, CA, USA. huijun1@yahoo.com
34. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. Year Published: 2007
Department of Pharmacology, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
35. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Year Published: 2007
Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Hermann Pressler Boulevard, Houston, TX 77030, USA.
36. The Women's Initiative for Nonsmoking (WINS) XI: age-related differences in smoking cessation responses among women with cardiovascular disease. Year Published: 2008
University of California San Francisco, San Francisco, CA, USA.
37. Cytisine for smoking cessation: a research agenda. Year Published: 2007
Institute of Social and Preventive Medicine, University of Geneva, CMU, Case Postale, CH-1211 Geneva 4, Switzerland. jean-francois.etter@imsp.unige.ch
38. Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake? Year Published: 2008
Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven Connecticut.
39. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Year Published: 2008
Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, San Francisco, California, USA. nbenowitz@medsfgh.ucsf.edu
40. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Year Published: 2008
Department of Medicine, University of California, San Francisco, California, USA. nbenowitz@medsfgh.ucsf.edu
41. Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake? Year Published: 2008
Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health, One Church Street, New Haven, CT 06510, USA. laura.grosso@yale.edu <laura.grosso@yale.edu>